EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut frailty in chronic heart failure: clinical determinants and distinct microbial signatures

Mengdie Hu, Jiahui Xiang, Xinyi Hou, Yuxuan Shao, Qin Peng, Chaofeng Li

Frontiers in Cardiovascular Medicine · 19.06.2026 · 13

DOI: 10.3389/fcvm.2026.1779873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 19.06.2026. Verfasst von Mengdie Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing University of Chinese Medicine, Nanjing, China. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gut frailty is a critical yet under-recognized sub-phenotype in chronic heart failure (CHF) that may exacerbate systemic inflammation. This study aimed to identify risk factors for gut frailty in CHF and characterize associated gut microbiome alterations.

Methods

In this cross-sectional study of 270 CHF patients, gut frailty was defined as a Gastrointestinal Symptom Rating Scale score of ≥3. Clinical determinants were identified via multivariable logistic regression. 16S rRNA sequencing was performed on a balanced sub-cohort ( n = 60) to analyze microbial diversity, taxonomy, and predicted metabolic functions.

Results

A meat-rich diet independently increased gut frailty risk (OR = 3.995; 95% CI: 1.107–16.110; P = 0.041), while vegetarian adherence was protective (OR = 0.148; 95% CI: 0.024–0.883; P = 0.035). Alpha-diversity was significantly reduced across all indices (Observed ASVs, Shannon, Chao1, ACE; all P < 0.0001), with distinct beta-diversity clustering (ANOSIM R = 0.2766, P = 0.001). The frail phenotype harbored fewer unique ASVs (76 vs. 142) and exhibited depletion of short-chain fatty acid producers ( Faecalibacterium , Coprococcus ) alongside enrichment of pathobionts and trimethylamine-producers ( Lachnoclostridium , Enterobacteriaceae ). Functionally, the microbiome shifted toward stress-responsive xenobiotic biodegradation, notably cytochrome P450 (log 2 fold change = 2.82).

Conclusion

Gut frailty in CHF constitutes a distinct syndrome modulated by diet and characterized by profound dysbiosis and metabolic reprogramming. Targeting the gut-heart axis through nutritional or microbiome-directed interventions may offer a novel strategy to mitigate frailty in heart failure.

Schlagwörter

Stichwörter der Autor:innen

chronic heart failuredietary patterndysbiosisgut frailtygut microbiota

Autor:innen und Institutionen

  • Nanjing University of Chinese Medicine, Nanjing, China.
  • Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.

Zitieren

APA

Hu, M., Xiang, J., Hou, X., Shao, Y., Peng, Q., & Li, C. (2026). Gut frailty in chronic heart failure: clinical determinants and distinct microbial signatures. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1779873

Vancouver

Hu M, Xiang J, Hou X, Shao Y, Peng Q, Li C. Gut frailty in chronic heart failure: clinical determinants and distinct microbial signatures. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1779873

BibTeX
@article{Hu2026,
  author = {Hu, Mengdie and Xiang, Jiahui and Hou, Xinyi and Shao, Yuxuan and Peng, Qin and Li, Chaofeng},
  title = {Gut frailty in chronic heart failure: clinical determinants and distinct microbial signatures},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1779873}
}
Kostenlos starten →